Relapse in adult idiopathic inflammatory myopathies: clinical predictors and the potential role of anti-NXP2 in a single-center retrospective cohort study.

M. Ekici İ. Y. İçli G. Yardımcı Z. Özsoy E. Ünaldı Büşra Fırlatan Gözde Sevgi Kart Bayram B. Bulat L. Kılıç U. Kalyoncu Ö. Karadağ Ş. Bilgen A. Ertenli S. Kiraz A. Akdoğan

Sep 2026 · Clinical Rheumatology · 0 citations · 30 references

Medicine

TL;DR

Younger age, anti-NXP2 positivity, and IVIG use independently increased relapse risk, whereas long-term maintenance therapy substantially delayed relapse, highlighting the need for long-term immunosuppression and close monitoring of high-risk subgroups.

DOI PubMed Semantic Scholar

View source

Similar papers

Aug 2026

Clinical characteristics, organ damage and survival in idiopathic inflammatory myopathies: a long-term retrospective cohort study

Ezgi Şahin, O. Uludag, Yasemin Yalçınkaya et al. · Rheumatology International · 0 citations

Open access Oct 2026

Trends in Hospitalizations of Patients with Idiopathic Inflammatory Myopathies: Long-Term Observational Study, 2010–2024

Background/Objectives: Idiopathic inflammatory myopathies (IIMs) are very rare, chronic, immune-mediated diseases that clinically manifest with myositis symptoms and extramuscular manifestations. The rarity of the disease makes it difficult to conduct double-blind studies, and large population-based studies are needed...

Maria Dutsch-Wicherek, Bartłomiej Wieleba, K. Lewtak et al. · Journal of Clinical Medicine · 0 citations

Review Aug 2026

Complete remission and relapse in the treatment of idiopathic inflammatory myopathies: a retrospective cohort study.

Naoki Kimura, Manami Nomura, R. Hanazawa et al. · Modern Rheumatology · 0 citations

Open access Aug 2026

Performance of IMACS Malignancy Risk Stratification in Idiopathic Inflammatory Myopathies: A Single-centre Retrospective Cohort Study from India

Background: Idiopathic inflammatory myopathies (IIMs) carry an increased malignancy risk. Although the International Myositis Assessment and Clinical Studies Group (IMACS) has proposed guidelines to screen malignancies, their applicability across populations remains uncertain. In this study, we analysed risk factors fo...

L. Kumari, C. Kavadichanda, Mamatha Gorijavulu et al. · Indian Journal of Rheumatolo... · 0 citations

Review Open access Sep 2026

Clinical Outcomes and Treatment Efficacy in Juvenile Myasthenia Gravis: A Retrospective Review From a Single Center.

INTRODUCTION/AIMS Early recognition and treatment are critical in juvenile myasthenia gravis (JMG), yet pediatric-specific evidence remains limited. We aimed to describe treatment patterns, remission rates, and predictors in a Canadian cohort. METHODS We conducted a retrospective study of patients under 18 years diag...

Tanitnun Paprad, E. Nigro, Z. Aleisa et al. · Muscle and Nerve · 0 citations

Sep 2026

Clinical Feature and Treatment Outcomes of Necrotizing Autoimmune Myopathy in a Referral Neurological Center in Thailand.

Patients with anti-SRP-associated NAM were relatively more severe, and cancer screening should be considered in anti-HMGCR patients, and Rituximab was beneficial in individual patients.

Sirilux Angsuwattanakul, Thanes Termglinjan, A. Rojana-udomsart · Journal of Clinical Neuromus... · 0 citations